Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12617000042347
ACTRN12617000042347
Withdrawn
Not Applicable

A Clinical Study To Investigate The Safety and Efficacy of W8biotic as a Weight Loss (meal replacement) Intervention in Overweight and Obese Adult Volunteers.

Medlab Clinical 0 sites10 target enrollmentJanuary 10, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsOverweightObese

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Overweight
Sponsor
Medlab Clinical
Enrollment
10
Status
Withdrawn
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 10, 2017
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Medlab Clinical

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
A clinical study to evaluate the safety and effectiveness of NOVOCART® 3D plus compared to the standard of care (microfracture) in the treatment of cartilage defects of the knee.
EUCTR2011-005798-22-DETETEC – Tissue Engineering Technologies – AG261
Active, not recruiting
Phase 1
A clinical study to evaluate the safety and effectiveness of NOVOCART® 3D plus compared to the standard of care (microfracture) in the treatment of cartilage defects of the knee.
EUCTR2011-005798-22-LVTETEC – Tissue Engineering Technologies – AG261
Active, not recruiting
Phase 1
A clinical study to evaluate the safety and effectiveness of NOVOCART® 3D plus compared to the standard of care (microfracture) in the treatment of cartilage defects of the knee.Repair of localized, full-thickness cartilage defects of the femoral condyle (medial, lateral or trochlea) of 2-6cm².MedDRA version: 20.0Level: PTClassification code 10052913Term: Cartilage operationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 21.1Level: LLTClassification code 10007705Term: Cartilage damageSystem Organ Class: 100000004863MedDRA version: 20.0Level: LLTClassification code 10057104Term: Cartilage repairSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: PTClassification code 10064112Term: Cartilage graftSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Body processes [G] - Cell Physiological Phenomena [G04]
EUCTR2011-005798-22-PLTETEC – Tissue Engineering Technologies – AG261
Active, not recruiting
Phase 1
A clinical study to evaluate the safety and effectiveness of NOVOCART® 3D plus compared to the standard of care (microfracture) in the treatment of cartilage defects of the knee.Repair of localized, full-thickness cartilage defects of the femoral condyle (medial, lateral or trochlea) of 2-6cm².MedDRA version: 20.0Level: PTClassification code 10052913Term: Cartilage operationSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 21.1Level: LLTClassification code 10007705Term: Cartilage damageSystem Organ Class: 100000004863MedDRA version: 20.0Level: LLTClassification code 10057104Term: Cartilage repairSystem Organ Class: 10042613 - Surgical and medical proceduresMedDRA version: 20.0Level: PTClassification code 10064112Term: Cartilage graftSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Body processes [G] - Cell Physiological Phenomena [G04]
EUCTR2011-005798-22-LTTETEC – Tissue Engineering Technologies – AG261
Withdrawn
Phase 3
A Clinical Study to Evaluate the Safety and Effectiveness of NOVOCART® 3D plus Compared to Microfracture in the Treatment of Articular Cartilage Defects of the Knee
NL-OMON40824TETEC AG30